GlassScriptPhysician profile
Ralph S Sando
NPI 1326015421
$9,813.06
in general payments reported to CMS, 2019-2025
29 companies · $1,823 in 2025
The $1,823 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,695 · 2020: $518 · 2021: $1,352 · 2022: $2,302 · 2023: $1,065 · 2024: $1,058 · 2025: $1,823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,945.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $2,393.61 | 2019-2025 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Alcon Vision LLC | $1,955.12 | 2019-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Oyster Point Pharma, INC. | $759.47 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $708.55 | 2019-2025 | Cequa |
| Abbvie INC. | $629.53 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Novartis Pharmaceuticals Corporation | $562.49 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $483.55 | 2024-2025 | Xdemvy |
| Allergan, INC. | $480.82 | 2019-2022 | |
| Lensar, INC. | $320.75 | 2025 | Lensar Laser System |
| Sight Sciences, INC. | $165.98 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb Americas INC. | $159.34 | 2022-2025 | Vyzulta, Xiidra |
| Quidel Corporation | $156.00 | 2019-2021 | |
| Ivantis, INC | $150.00 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $130.78 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $124.66 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $85.73 | 2024 | Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Dompe US, INC. | $79.53 | 2024-2025 | Oxervate |
| New World Medical,INC. | $77.63 | 2023 | |
| Harrow Eye, LLC | $65.28 | 2024-2025 | Vevye |
| Glaukos Corporation | $62.56 | 2025 | Idosetr |
| Shire North American Group INC | $62.15 | 2019 | |
| Eyevance Pharmaceuticals LLC | $62.12 | 2020-2022 | |
| Mallinckrodt Enterprises LLC | $28.48 | 2019 | |
| Coopervision INC. | $27.62 | 2025 | Myday Contact Lens |
| Ani Pharmaceuticals, INC. | $20.95 | 2025 | Purified Cortrophin Gel |
| Akorn, INC. | $18.02 | 2019 | |
| Biotissue Holdings INC. | $16.23 | 2019 | |
| Thea Pharma INC. | $15.05 | 2025 | Iyuzeh |
| Horizon Therapeutics Plc | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Sando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.